BioNTech to price vaccine below market rates, varying between regions

The vaccine was on Monday shown to be 90% effective, based on preliminary trial results, a key milestone in the war against a virus that has killed over a million people worldwide.

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020

(photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)

ByREUTERS

NOVEMBER 10, 2020 19:31

BioNTech to price vaccine below market rates, varying between regions

The vaccine was on Monday shown to be 90% effective, based on preliminary trial results, a key milestone in the war against a virus that has killed over a million people worldwide.

A dentist explains the common mistakes in morning brushing

Patients use bots to fight health insurance claim denials

BioNTech to price vaccine below market rates, varying between regions

The vaccine was on Monday shown to be 90% effective, based on preliminary trial results, a key milestone in the war against a virus that has killed over a million people worldwide.

See more on